Patients meeting the eligibility criteria and scheduled for HoLEP surgery will provide written informed consent prior to enrollment. Participants will be randomly assigned to either the intervention or control group. Upon acceptance, baseline demographic and clinical data will be collected. In the intervention group, standardized pelvic floor muscle training (PFMT) will be administered individually the day before surgery. Participants will be instructed to perform slow and rapid pelvic floor muscle contractions. The same supervised exercise protocol will be repeated on days 1 and 2 post-surgery. After discharge, participants will be contacted weekly during the first month and monthly during the second and third months to encourage adherence to PFMT. At the end of the third month post-surgery, urinary incontinence will be assessed using the Severity Index of Urinary Incontinence (ISI) and the International Urinary Incontinence Advisory Questionnaire - Short Form (ICIQ-SF). The control group will receive routine pre- and post-operative care without supervised PFMT and will undergo the same outcome assessments at the third month post-surgery.
Age range
80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Urinary incontinence severity index
Timeframe: Weekly during the first month after discharge, and once each month during the 2nd and 3rd months.